Review of equine piroplasmosis

Journal of Veterinary Internal Medicine

Volumn 27, Issue 6, 2013, Pages 1334-1346

  Wise, L N ^a,b   Kappmeyer, L S ^b   Mealey, R H ^a   Knowles, D P ^a,b,c  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c OIE Reference Laboratory for Equine Piroplasmosis   (United States)

Author keywords

Anemia; Babesia caballi; Erythrocytic parasite; Theileria equi; Tick transmitted

Indexed keywords

BABESIA CABALLI; EQUIDAE; IXODIDA; THEILERIA; THEILERIA EQUI;

ANEMIA; ANIMAL; ANIMAL DISEASE; BABESIA; BABESIA CABALLI; BLOOD; DISEASE TRANSMISSION; ERYTHROCYTIC PARASITE; GROWTH, DEVELOPMENT AND AGING; HORSE; HORSE DISEASE; PARASITOLOGY; PIROPLASMOSIS; PREVALENCE; REVIEW; THEILERIA; THEILERIA EQUI; THEILERIOSIS; TICK; TICK-TRANSMITTED; UNITED STATES;

ANEMIA; BABESIA CABALLI; ERYTHROCYTIC PARASITE; THEILERIA EQUI; TICK-TRANSMITTED;

ANIMALS; BABESIA; BABESIOSIS; HORSE DISEASES; HORSES; PREVALENCE; THEILERIA; THEILERIASIS; TICKS; UNITED STATES;

EID: 84887614908     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12168     Document Type: Review

References (135)

1. Friedhoff KT, Tenter AM, Muller I. Haemoparasites of equines: Impact on international trade of horses. Rev Sci Tech 1990;9:1187-1194.
2. Schein E. Equine babesiosis. Ristic M,Babesiosis of Domestic Animals and Man. Boca Raton, FL: CRC; 1988:197-208.
3. de Waal DT. Equine piroplasmosis: A review. Br Vet J 1992;148:6-14.
4. Maurer FD. Equine piroplasmosis-Another emerging disease. J Am Vet Med Assoc 1962;141:699-702.
5. Friedhoff KT, Soule C. An account on equine babesioses. Rev Sci Tech 1996;15:1191-1201.
6. Butler CM, Sloet van Oldruitenborgh-Oosterbaan MM, Stout TAE, et al. Prevalence of the causative agents of equine piroplasmosis in the South West of The Netherlands and the identification of two autochthonous clinical Theileria equi infections. Vet J 2012;193:381-385.
7. Ueti MW, Mealey RH, Kappmeyer LS, et al. Re-emergence of the apicomplexan Theileria equi in the United States: Elimination of persistent infection and transmission risk. PLoS One 2012;7:e44713.
8. World Animal Health Information Database (WAHID). 2012. Available at: http://www.oie.int/fileadmin/Home/eng/Animal_Health_in_the_World/docs/pdf/EQUINE_PRIOPLASMOSIS_FINAL.pdf. Accessed April 1, 2013.
9. Scoles GA, Hutcheson HJ, Schlater JL, et al. Equine piroplasmosis associated with Amblyomma cajennense ticks, Texas, USA. Emerg Infect Dis 2011;17:1903-1905.
10. Kappmeyer LS, Thiagarajan M, Herndon DR, et al. Comparative genomic analysis and phylogenetic position of Theileria equi. BMC Genomics 2012;13:603.
11. Mehlhorn H, Schein E. Redescription of Babesia equi Laveran, 1901 as Theileria equi Mehlhorn, Schein 1998. Parasitol Res 1998;84:467-475.
12. Laveran A. Contribution à l'étude du Piroplasma equi. CR Seances Soc Biol Paris 1901;53:2.
13. Koch R. BeitraÈ ge zur entwicklungsgeschichte der piroplasmen. Z Hyg Infektionskrankh 1906;54:9.
14. Nuttal GH, Strickland C. Die parasiten der pferdepiroplasmose response der biliary fever. Zentralbl Bakteriol 1910;1:2.
15. Allsopp MT, Lewis BD, Penzhorn BL. Molecular evidence for transplacental transmission of Theileria equi from carrier mares to their apparently healthy foals. Vet Parasitol 2007;148:130-136.
16. Allsopp MT, Allsopp BA. Molecular sequence evidence for the reclassification of some Babesia species. Ann N Y Acad Sci 2006;1081:509-517.
17. Allsopp MT, Cavalier-Smith T, De Waal DT, et al. Phylogeny and evolution of the piroplasms. Parasitology 1994;108(Pt 2):147-152.
18. Uilenberg G. Babesia-A historical overview. Vet Parasitol 2006;138:3-10.
19. Thompson PH. Ticks as vectors of equine piroplasmosis. J Am Vet Med Assoc 1969;155:454-457.
20. Ueti MW, Palmer GH, Scoles GA, et al. Persistently infected horses are reservoirs for intrastadial tick-borne transmission of the apicomplexan parasite Babesia equi. Infect Immun 2008;76:3525-3529.
21. Schwint ON, Knowles DP, Ueti MW, et al. Transmission of Babesia caballi by Dermacentor nitens (Acari: Ixodidae) is restricted to one generation in the absence of alimentary reinfection on a susceptible equine host. J Med Entomol 2008;45:1152-1155.
22. Stiller D, Goff WL, Johnson LW, et al. Dermacentor variabilis and Boophilus microplus (Acari: Ixodidae): Experimental vectors of Babesia equi to equids. J Med Entomol 2002;39:667-670.
23. Holbrook AA, Anthony DW, Johnson AJ. Observations on the development of Babesia caballi (Nuttall) in the tropical horse tick Dermacentor nitens Neumann. J Protozool 1968;15:391-396.
24. Roby TO, Anthony DW. Transmission of equine piroplasmosis by Dermacentor nitens Neumann. J Am Vet Med Assoc 1963;142:768-769.
25. United States Department of Agriculture APHIS National Center for Risk Analysis. Equine piroplasmosis domestic pathways assessment 2011: Pathways assessment for the spread of the causative agents of equine piroplasmosis from the movement of a horse from a quarantined premises within the contiguous United States Updated December 2011. Available at: http://www.aphis.usda.gov/animal_health/emergingissues/downloads/epdomesticpathwaysfinalapril11.pdf. Accessed February 12, 2013.
26. Basset J, Auger L. Piroplasmose vraie du cheval (P. caballi) dans le sudest. Comp Rend Soc Biol 1931;107:629.
27. Knowles DP Jr, Kappmeyer LS, Stiller D, et al. Antibody to a recombinant merozoite protein epitope identifies horses infected with Babesia equi. J Clin Microbiol 1992;30:3122-3126.
28. Sonenshine DE. Biology of Ticks. New York, NY: Oxford University Press; 1991.
29. Asgarali Z, Coombs DK, Mohammed F, et al. A serological study of Babesia caballi and Theileria equi in Thoroughbreds in Trinidad. Vet Parasitol 2007;144:167-171.
30. Rampersad J, Cesar E, Campbell MD, et al. A field evaluation of PCR for the routine detection of Babesia equi in horses. Vet Parasitol 2003;114:81-87.
31. Viljoen A, Saulez MN, Donnellan CM, et al. After-hours equine emergency admissions at a university referral hospital (1998-2007): Causes and interventions. J S Afr Vet Assoc 2009;80:169-173.
32. de Waal DT, van Heerden J. Equine piroplasmosis. Coetzer JAW, Tustin RC, Infectious Diseases of Livestock, 2ndCape Town, South Africa: Oxford University Press; 2004:425-433.
33. Xu Y, Zhang S, Huang X, et al. Seroepidemiologic studies on Babesia equi and Babesia caballi infections in horses in Jilin province of China. J Vet Med Sci 2003;65:1015-1017.
34. Xuan X, Chahan B, Huang X, et al. Diagnosis of equine piroplasmosis in Xinjiang province of China by the enzyme-linked immunosorbent assays using recombinant antigens. Vet Parasitol 2002;108:179-182.
35. Cantu-Martinez MA, Segura-Correa JC, Silva-Paez ML, et al. Prevalence of antibodies to Theileria equi and Babesia caballi in horses from northeastern Mexico. J Parasitol 2012;98:869-870.
36. World Organization of Animal Health (OIE) Website. Available at: http://www.oie.int. Updated: 2013. April 1, 2013.
37. Short MA, Clark CK, Harvey JW, et al. Outbreak of equine piroplasmosis in Florida. J Am Vet Med Assoc 2012;240:588-595.
38. Bryant JE, Anderson JB, Willers KH. Control of equine piroplasmosis in Florida. J Am Vet Med Assoc 1969;154:1034-1036.
39. Taylor WM, Bryant JE, Anderson JB, et al. Equine piroplasmosis in the United States-A review. J Am Vet Med Assoc 1969;155:915-919.
40. Ueti MW, Palmer GH, Kappmeyer LS, et al. Ability of the vector tick Boophilus microplus to acquire and transmit Babesia equi following feeding on chronically infected horses with low-level parasitemia. J Clin Microbiol 2005;43:3755-3759.
41. De Waal DT. The transovarial transmission of Babesia caballi by Hyalomma truncatum. Onderstepoort J Vet Res 1990;57:99-100.
42. Ikadai H, Sasaki M, Ishida H, et al. Molecular evidence of Babesia equi transmission in Haemaphysalis longicornis. Am J Trop Med Hyg 2007;76:694-697.
43. Moltmann UG, Mehlhorn H, Schein E, et al. Ultrastructural study on the development of Babesia equi (Coccidia: Piroplasmia) in the salivary glands of its vector ticks. J Protozool 1983;30:218-225.
44. Estrada-Pena A, Guglielmone AA, Mangold AJ. The distribution and ecological 'preferences' of the tick Amblyomma cajennense (Acari: Ixodidae), an ectoparasite of humans and other mammals in the Americas. Ann Trop Med Parasitol 2004;98:283-292.
45. Schein E, Rehbein G, Voigt WP, et al. Babesia equi (Laveran 1901) 1. Development in horses and in lymphocyte culture. Tropenmed Parasitol 1981;32:223-227.
46. Moltmann UG, Mehlhorn H, Schein E, et al. Fine structure of Babesia equi Laveran, 1901 within lymphocytes and erythrocytes of horses: An in vivo and in vitro study. J Parasitol 1983;69:111-120.
47. Zapf F, Schein E. The development of Babesia (Theileria) equi (Laveran, 1901) in the gut and the haemolymph of the vector ticks. Hyalomma species. Parasitol Res 1994;80:297-302.
48. Guimaraes AM, Lima JD, Ribeiro MF, et al. Ultrastructure of sporogony in Babesia equi in salivary glands of adult female Boophilus microplus ticks. Parasitol Res 1998;84:69-74.
49. Gerstenberg C, Allen WR, Phipps LP. The mechanical transmission of Babesia equi infection in a British herd of horses. Proceedings of the Eighth International Conference on Equine Infectious Diseases. Dubai, United Arab Emirates, 1998:100.
50. Simpson CF, Neal FC. Ultrastructure of Babesia equi in ponies treated with imidocarb. Am J Vet Res 1980;41:267-271.
51. Kuttler KL, Gipson CA, Goff WL, et al. Experimental Babesia equi infection in mature horses. Am J Vet Res 1986;47:1668-1670.
52. Allen PC, Frerichs WM, Holbrook AA. Experimental acute Babesia caballi infections. I. Red blood cell dynamics. Exp Parasitol 1975;37:67-77.
53. Ambawat HK, Malhotra DV, Kumar S, et al. Erythrocyte associated haemato-biochemical changes in Babesia equi infection experimentally produced in donkeys. Vet Parasitol 1999;85:319-324.
54. de Waal DT, van Heerden J, Potgieter FT. An investigation into the clinical pathological changes and serological response in horses experimentally infected with Babesia equi and Babesia caballi. Onderstepoort J Vet Res 1987;54:561-568.
55. Allen PC, Frerichs WM, Holbrook AA. Experimental acute Babesia caballi infections. II. Response of platelets and fibrinogen. Exp Parasitol 1975;37:373-379.
56. Donnellan CM, Marais HJ. Equine piroplasmosis. Mair TS, Hutchinson RE, Infectious Diseases of the Horse. Cambridgeshire, England, UK: EVJ Ltd; 2009:333-340.
57. Georges KC, Ezeokoli CD, Sparagano O, et al. A case of transplacental transmission of Theileria equi in a foal in Trinidad. Vet Parasitol 2011;175:363-366.
58. Chhabra S, Ranjan R, Uppal S, et al. Transplacental transmission of Babesia equi (Theileria equi) from carrier mares to foals. J Parasit Dis 2012;36:31-33.
59. Phipps LP, Otter A. Transplacental transmission of Theileria equi in two foals born and reared in the United Kingdom. Vet Rec 2004;154:406-408.
60. Lewis BD, Penzhorn BL, Volkmann DH. Could treatment of pregnant mares prevent abortions due to equine piroplasmosis? J S Afr Vet Assoc 1999;70:90-91.
61. Metcalf ES. The role of international transport of equine semen on disease transmission. Anim Reprod Sci 2001;68:229-237.
62. Pitel P-H, Pronost S, Scrive T, et al. Molecular detection of Theileria equi and Babesia caballi in the bone marrow of asymptomatic horses. Vet Parasitol 2010;170:182-184.
63. Holbrook AA. Biology of equine piroplasmosis. J Am Vet Med Assoc 1969;155:453-454.
64. Zobba R, Ardu M, Niccolini S, et al. Clinical and laboratory findings in equine piroplasmosis. J Eq Vet Sci 2008;28:301-308.
65. Diana A, Guglielmini C, Candini D, et al. Cardiac arrhythmias associated with piroplasmosis in the horse: A case report. Vet J 2007;174:193-195.
66. Hailat NQ, Lafi SQ, al-Darraji AM, et al. Equine babesiosis associated with strenuous exercise: Clinical and pathological studies in Jordan. Vet Parasitol 1997;69:1-8.
67. Al-Saad K. Acute babesiosis in foals. J Anim Vet Adv 2009;8:5.
68. Butler CM, van Gils JA, van der Kolk JH. A literature review of equine piroplasmosis after an episode of acute babesiosis in a Dutch Standardbred foal after a stay in Normandy. Tijdschr Diergeneeskd 2005;130:726-731.
69. Erbsloh JK. Babesiosis in the newborn foal. J Reprod Fertil Suppl 1975;23:725-726.
70. Purchase HS. Piroplasmosis in foal at birth. Vet Rec 1947;59:449.
71. Silvey RE. Babesiosis in a foal. Vet Rec 1996;139:428.
72. Neitz WO. Classification, transmission, and biology of piroplasms of domestic animals. Ann N Y Acad Sci 1956;64:56-111.
73. United States Department of Agriculture Animal and Plant Inspection Service. Equine piroplasmosis. Updated November 2012. Available at: http://www.aphis.usda.gov/animal_health/animal_diseases/piroplasmosis. Accessed February 12, 2013.
74. Alward A, Corriher CA, Barton MH, et al. Red maple (Acer rubrum) leaf toxicosis in horses: A retrospective study of 32 cases. J Vet Intern Med 2006;20:1197-1201.
75. Camacho AT, Guitian FJ, Pallas E, et al. Theileria (Babesia) equi and Babesia caballi infections in horses in Galicia, Spain. Trop Anim Health Prod 2005;37:293-302.
76. Rudolph W, Correa J, Zurita L, et al. Equine piroplasmosis: Leukocytic response to Babesia equi (Laveran, 1901) infection in Chile. Br Vet J 1975;131:601-609.
77. Frerichs WM, Holbrook AA. Feeding mechanisms of Babesia equi. J Protozool 1974;21:707-709.
78. Mahoney DF, Wright IG, Frerichs WM, et al. The identification of Babesia equi in Australia. Aust Vet J 1977;53:461-464.
79. Frerichs WM, Johnson AJ, Holbrook AA. Equine piroplasmosis: Attempts to infect laboratory animals with Babesia equi. Am J Vet Res 1969;30:1333-1336.
80. Guimarães AM, Lima JD, Tafuri WL, et al. Clinical and histopathological aspects of splenectomized foals infected by Babesia equi. J Eq Vet Sci 1997;17:211-216.
81. De Waal DT, Van Heerden J, Van den Berg SS, et al. Isolation of pure Babesia equi and Babesia caballi organisms in splenectomized horses from endemic areas in South Africa. Onderstepoort J Vet Res 1988;55:33-35.
82. Banerjee DP, Singh B, Gautam OP, et al. Cell-mediated immune response in equine babesiosis. Trop Anim Health Prod 1977;9:153-158.
83. Kumar S, Malhotra DV, Dhar S, et al. Vaccination of donkeys against Babesia equi using killed merozoite immunogen. Vet Parasitol 2002;106:19-33.
84. Hanafusa Y, Cho KO, Kanemaru T, et al. Pathogenesis of Babesia caballi infection in experimental horses. J Vet Med Sci 1998;60:1127-1132.
85. Knowles DP Jr, Kappmeyer LS, Perryman LE. Specific immune responses are required to control parasitemia in Babesia equi infection. Infect Immun 1994;62:1909-1913.
86. Magnuson NS, Perryman LE, Wyatt CR, et al. Continuous cultivation of equine lymphocytes: Evidence for occasional T cell-like maturation events in horses with hereditary severe combined immunodeficiency. J Immunol 1984;133:2518-2524.
87. McGuire TC, Banks KL, Poppie MJ. Combined immunodeficiency in horses: Characterization of the lymphocyte defect. Clin Immunol Immunopathol 1975;3:555-566.
88. Perryman LE, McGuire TC, Crawford TB. Maintenance of foals with combined immunodeficiency: Causes and control of secondary infections. Am J Vet Res 1978;39:1043-1047.
89. Perryman LE, O'Rourke KI, McGuire TC. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J Virol 1988;62:3073-3076.
90. Shin EK, Perryman LE, Meek K. A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation. J Immunol 1997;158:3565-3569.
91. Wiler R, Leber R, Moore BB, et al. Equine severe combined immunodeficiency: A defect in V(D)J recombination and DNA-dependent protein kinase activity. Proc Natl Acad Sci U S A 1995;92:11485-11489.
92. Cunha CW, McGuire TC, Kappmeyer LS, et al. Development of specific immunoglobulin Ga (IgGa) and IgGb antibodies correlates with control of parasitemia in Babesia equi infection. Clin Vaccine Immunol 2006;13:297-300.
93. Lewis MJ, Wagner B, Woof JM. The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies. Mol Immunol 2008;45:818-827.
94. Mealey RH, Kappmeyer LS, Ueti MW, et al.Protective effects of passively transferred merozoite-specific antibodies against Theileria equi in horses with severe combined immunodeficiency. Clin Vaccine Immunol 2012;19:100-104.
95. Yokoyama N, Okamura M, Igarashi I. Erythrocyte invasion by Babesia parasites: Current advances in the elucidation of the molecular interactions between the protozoan ligands and host receptors in the invasion stage. Vet Parasitol 2006;138:22-32.
96. Oladosu LA. Effects of intravenous corticosteroid on the pathogenicity of Babesia equi infection of donkeys (Equus asinus). Zentralbl Veterinarmed B 1988;35:509-514.
97. Oladosu LA, Olufemi BE. Haematology of experimental babesiosis and ehrlichiosis in steroid immunosuppressed horses. Zentralbl Veterinarmed B 1992;39:345-352.
98. Equine piroplasmosis terrestrial manual 2008. Updated: 2012. http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.05.08_EQUINE_PIROPLASMOSIS.pdf. Accessed April 1, 2013.
99. Brüning A. Equine piroplasmosis an update on diagnosis, treatment and prevention. Br Vet J 1996;152:139-151.
100. Weiland G. Species-specific serodiagnosis of equine piroplasma infections by means of complement fixation test (CFT), immunofluorescence (IIF), and enzyme-linked immunosorbent assay (ELISA). Vet Parasitol 1986;20:43-48.
101. McGuire TC, Van Hoosier GL Jr, Henson JB. The complement-fixation reaction in equine infectious anemia: Demonstration of inhibition by IgG (T). J Immunol 1971;107:1738-1744.
102. Donnelly J, Phipps LP, Watkins KL. Evidence of maternal antibodies to Babesia equi and B caballi in foals of seropositive mares. Equine Vet J 1982;14:126-128.
103. Tenter AM, Friedhoff KT. Serodiagnosis of experimental and natural Babesia equi and B. caballi infections. Vet Parasitol 1986;20:49-61.
104. Animal and Plant Health Inspection Service Website. Animal Health Laboratory Information and Services. Updated November 2012. Available at: http://www.aphis.usda.gov/animal_health/lab_info_services. Accessed February 12, 2013.
105. Knowles DP Jr, Perryman LE, Kappmeyer LS, et al. Detection of equine antibody to Babesia equi merozoite proteins by a monoclonal antibody-based competitive inhibition enzyme-linked immunosorbent assay. J Clin Microbiol 1991;29:2056-2058.
106. Knowles DP Jr, Perryman LE, Goff WL, et al. A monoclonal antibody defines a geographically conserved surface protein epitope of Babesia equi merozoites. Infect Immun 1991;59:2412-2417.
107. Cunha CW, Kappmeyer LS, McGuire TC, et al. Conformational dependence and conservation of an immunodominant epitope within the Babesia equi erythrocyte-stage surface protein equi merozoite antigen 1. Clin Diagn Lab Immunol 2002;9:1301-1306.
108. Kappmeyer LS, Perryman LE, Hines SA, et al. Detection of equine antibodies to Babesia caballi by recombinant B. caballi rhoptry-associated protein 1 in a competitive-inhibition enzyme-linked immunosorbent assay. J Clin Microbiol 1999;37:2285-2290.
109. Bhoora R, Quan M, Zweygarth E, et al. Sequence heterogeneity in the gene encoding the rhoptry-associated protein-1 (RAP-1) of Babesia caballi isolates from South Africa. Vet Parasitol 2010;169:279-288.
110. Bhoora R, Quan M, Matjila PT, et al. Sequence heterogeneity in the equi merozoite antigen gene (ema-1) of Theileria equi and development of an ema-1-specific TaqMan MGB assay for the detection of T. equi. Vet Parasitol 2010;172:33-45.
111. Kumar S, Kumar Y, Malhotra DV, et al. Standardisation and comparison of serial dilution and single dilution enzyme linked immunosorbent assay (ELISA) using different antigenic preparations of the Babesia (Theileria) equi parasite. Vet Res 2003;34:71-83.
112. Katz J, Dewald R, Nicholson J. Procedurally similar competitive immunoassay systems for the serodiagnosis of Babesia equi, Babesia caballi, Trypanosoma equiperdum, and Burkholderia mallei infection in horses. J Vet Diagn Invest 2000;12:46-50.
113. Battsetseg B, Xuan X, Ikadai H, et al. Detection of Babesia caballi and Babesia equi in Dermacentor nuttalli adult ticks. Int J Parasitol 2001;31:384-386.
114. Bashiruddin JB, Camma C, Rebelo E. Molecular detection of Babesia equi and Babesia caballi in horse blood by PCR amplification of part of the 16S rRNA gene. Vet Parasitol 1999;84:75-83.
115. Nicolaiewsky TB, Richter MF, Lunge VR, et al. Detection of Babesia equi (Laveran, 1901) by nested polymerase chain reaction. Vet Parasitol 2001;101:9-21.
116. Bhoora R, Quan M, Franssen L, et al. Development and evaluation of real-time PCR assays for the quantitative detection of Babesia caballi and Theileria equi infections in horses from South Africa. Vet Parasitol 2010;168:201-211.
117. Schwint ON, Ueti MW, Palmer GH, et al. Imidocarb dipropionate clears persistent Babesia caballii infection with elimination of transmission potential. Antimicrob Agents Chemother 2009;53:4327-4332.
118. Ueti MW, Palmer GH, Kappmeyer LS, et al. Expression of equi merozoite antigen 2 during development of Babesia equi in the midgut and salivary gland of the vector tick Boophilus microplus. J Clin Microbiol 2003;41:5803-5809.
119. Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: Uses, limitations, and future applications in acute-care settings. Lancet Infect Dis 2004;4:337-348.
120. Grause JF, Ueti MW, Nelson JT, et al. Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses. Vet J 2013;196:541-546.
121. Nagai A, Yokoyama N, Matsuo T, et al. Growth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures. Antimicrob Agents Chemother 2003;47:800-803.
122. Frerichs WM, Allen PC, Holbrook AA. Equine piroplasmosis (Babesia equi): Therapeutic trials of imidocarb dihydrochloride in horses and donkeys. Vet Rec 1973;93:73-75.
123. Frerichs WM, Holbrook AA. Treatment of equine piroplasmosis (B caballi) with imidocarb dipropionate. Vet Rec 1974;95:188-189.
124. Kumar S, Gupta AK, Pal Y, et al. In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys. J Vet Med Sci 2003;65:1171-1177.
125. Zaugg JL, Lane VM. Evaluations of buparvaquone as a treatment for equine babesiosis (Babesia equi). Am J Vet Res 1989;50:782-785.
126. Bork S, Yokoyama N, Ikehara Y, et al. Growth-inhibitory effect of heparin on Babesia parasites. Antimicrob Agents Chemother 2004;48:236-241.
127. Bork S, Yokoyama N, Matsuo T, et al. Growth inhibitory effect of triclosan on equine and bovine Babesia parasites. Am J Trop Med Hyg 2003;68:334-340.
128. Bork S, Yokoyama N, Matsuo T, et al. Clotrimazole, ketoconazole, and clodinafop-propargyl as potent growth inhibitors of equine Babesia parasites during in vitro culture. J Parasitol 2003;89:604-606.
129. Meyer C, Guthrie AJ, Stevens KB. Clinical and clinicopathological changes in 6 healthy ponies following intramuscular administration of multiple doses of imidocarb dipropionate. J S Afr Vet Assoc 2005;76:26-32.
130. Bacchi CJ, Nathan HC, Hutner SH, et al. Prevention by polyamines of the curative effect of amicarbalide and imidocarb for Trypanosoma brucei infections in mice. Biochem Pharmacol 1981;30:883-886.
131. McHardy N, Woollon RM, Clampitt RB, et al. Efficacy, toxicity and metabolism of imidocarb dipropionate in the treatment of Babesia ovis infection in sheep. Res Vet Sci 1986;41:14-20.
132. Belloli C, Crescenzo G, Lai O, et al. Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration. Equine Vet J 2002;34:625-629.
133. Adams LG. Clinicopathological aspects of imidocarb dipropionate toxicity in horses. Res Vet Sci 1981;31:54-61.
134. Rashid H, Chaudhry M, Rashid H, et al. Comparative efficacy of diminazene diaceturate and diminazene aceturate for the treatment of babesiosis in horses. Trop Anim Health Prod 2008;40:463-467.
135. Wise LN, Ueti MW, Kappmeyer LS, et al. In vitro activity of ponazuril against Theileria equi. Vet Parasitol 2012;185:282-285.